Your browser doesn't support javascript.
loading
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.
Shiu, K-K; Wetterskog, D; Mackay, A; Natrajan, R; Lambros, M; Sims, D; Bajrami, I; Brough, R; Frankum, J; Sharpe, R; Marchio, C; Horlings, H; Reyal, F; van der Vijver, M; Turner, N; Reis-Filho, J S; Lord, C J; Ashworth, A.
Affiliation
  • Shiu KK; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Wetterskog D; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Mackay A; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Natrajan R; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Lambros M; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Sims D; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Bajrami I; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Brough R; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Frankum J; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Sharpe R; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Marchio C; Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy.
  • Horlings H; Department of Pathology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Reyal F; Department of Pathology, Academic Medical Centre, Amsterdam, The Netherlands.
  • van der Vijver M; Department of Pathology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Turner N; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Reis-Filho JS; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Lord CJ; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Ashworth A; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Oncogene ; 33(5): 619-31, 2014 Jan 30.
Article in En | MEDLINE | ID: mdl-23334330
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Amplification / Receptor, ErbB-2 / Transcription Factor AP-2 Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2014 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Amplification / Receptor, ErbB-2 / Transcription Factor AP-2 Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2014 Type: Article Affiliation country: United kingdom